IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Medicxi Ventures Management (Jersey) Ltd

Q1 2025 Holdings

Filed 2025-04-11 | 5 holdings | $437.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Centessa Pharmaceuticals PLC(CNTA)SPONSORED ADS152309100$287.1M19,963,15765.6%
Newamsterdam Pharma Company(NAMS)ORDINARY SHARESN62509109$58.7M2,869,56513.4%
Phathom Pharmaceuticals Inc(PHAT)COM71722W107$46.8M7,464,57210.7%
Rapt Therapeutics Inc(RAPTEUR)COM75382E109$27.3M22,352,0006.2%
Aura Biosciences Inc(AURA)COM05153U107$17.8M3,039,8924.1%